• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.66% Nasdaq Down1.05%

    Enzon Pharmaceuticals Inc. (ENZN)

    1.02 Up 0.04(4.08%) Sep 4, 3:59PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Enzon Pharmaceuticals Inc.
    20 Kingsbridge Road
    Piscataway, NJ 08854
    United States - Map
    Phone: 732-980-4500
    Website: http://www.enzon.com

    Index Membership:N/A
    Full Time Employees:1

    Business Summary 

    Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn’s disease. The company was founded in 1981 and is headquartered in Piscataway, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Enzon Pharmaceuticals Inc.

    Corporate Governance 
    Enzon Pharmaceuticals Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 7. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 6; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Richard L. Feinstein CPA, 72
    Principal Financial Officer, Principal Accounting Officer and VP of Fin.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders